NS
SANA icon

NBC Securities’s Sana Biotechnology SANA Stock Holding History

NBC Securities’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.2K Buy
14,373
+5,333
+59% +$17.2K ﹤0.01% 1291
2026
Q1 		$26K Buy
9,040
+6,940
+330% +$27.3K ﹤0.01% 1598
2025
Q4 		$8.55K Buy
+2,100
New +$9.4K ﹤0.01% 2068

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

NBC Securities's SANA Position: Q2 2026 in Review

NBC Securities increased its Sana Biotechnology (SANA) stake by 59% in Q2 2026, buying an estimated $17.2K and bringing the position to 14,373 shares worth $50.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1291.

NBC Securities first reported a position in SANA in Q4 2025 and has held it in 3 quarters since. 212 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • NBC Securities held 14,373 shares of Sana Biotechnology worth $50.2K as of Q2 2026.
  • NBC Securities bought 5,333 Sana Biotechnology shares in Q2 2026, an estimated $17.2K.
  • Sana Biotechnology made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #1291 holding.
  • NBC Securities first reported a position in Sana Biotechnology in Q4 2025 and has held it in 3 quarters since.
  • 212 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.